Company attributes
B2X
Founder
AngelList URL
Legal Name
MyoKardia, Inc.
Parent Organization
Legal classification
Spun Out From
Number of Employees (Ranges)
201 – 500
Phone Number
+18003322056
Full Address
1000 Sierra Point Parkway Brisbane, CA 94005 United States
CIK Number
Place of Incorporation
DUNS Number
0786980880
IRS Number
455,500,5520
Founded Date
2012
Total Funding Amount (USD)
98,000,659
Latest Funding Round Date
April 30, 2015
Competitors
Acquisition Transaction
Latest Funding Type
NAICS Code
325,4120
CAGE Code
8B0J80
Patents Assigned (Count)
8
Wellfound ID
Other attributes
Acquirer
Company Operating Status
Active
SIC Code
2,8340
MyoKarda was a clinical-stage biopharmaceutical company developing precision medicine approaches to discover, develop and commercialize targeted therapies for the treatment of serious cardiovascular diseases. The company was acquired by Bristol Myers Squibb in October 2020.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
